an increasing trendP = 0.054
When the outlying data points (January 2017 and December 2018) were excluded, the incidence of HO-CDI showed an increasing trend, without statistical significance ( P = 0.054).
When the outlying data points (January 2017 and December 2018) were excluded, the incidence of HO-CDI showed an increasing trend, without statistical significance ( P = 0.054).
Antibiotic consumption The consumption of all classes of intravenous antibiotics evaluated in this study, except BLBLIs, showed a decreasing trend in use; specifically, a significant decrease in fluoroquinolones, glycopeptides, and clindamycin.